[1]
|
Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249.
https://doi.org/10.3322/caac.21660
|
[2]
|
Qiu, H., Cao, S. and Xu, R. (2021) Cancer Incidence, Mortality, and Bur-den in China: A Time-Trend Analysis and Comparison with the United States and United Kingdom Based on the Global Epidemiological Data Released in 2020. Cancer Communications (London), 41, 1037-1048. https://doi.org/10.1002/cac2.12197
|
[3]
|
Parker, C., Castro, E., Fizazi, K., et al. (2020) Prostate Cancer: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up. Annals of Oncology, 31, 1119-1134. https://doi.org/10.1016/j.annonc.2020.06.011
|
[4]
|
Kuten, J., Kesler, M. and Even-Sapir, E. (2021) The Role of PSMA PET/CT in Imaging Prostate Cancer. Harefuah, 160, 455-461.
|
[5]
|
Klingenberg, S., Jochumsen, M.R., Ulhøi, B.P., et al. (2021) 68Ga-PSMA PET/CT for Primary Lymph Node and Distant Metastasis NM Staging of High-Risk Prostate Cancer. Journal of Nuclear Medicine, 62, 214-220.
https://doi.org/10.2967/jnumed.120.245605
|
[6]
|
Maurer, T., Eiber, M., Schwaiger, M., et al. (2016) Current Use of PSMA-PET in Prostate Cancer Management. Nature Reviews Urology, 13, 226-235. https://doi.org/10.1038/nrurol.2016.26
|
[7]
|
Bagguley, D., Ong, S., Buteau, J.P., et al. (2021) Role of PSMA PET/CT Imaging in the Diagnosis, Staging and Restaging of Prostate Cancer. Future Oncology, 17, 2225-2241. https://doi.org/10.2217/fon-2020-1293
|
[8]
|
Barbosa, Á.R.G., Amaral, B.S., Lourenço, D.B., et al. (2022) Accura-cy of 68Ga-PSMA PET-CT and PET-MRI in Lymph Node Staging for Localized Prostate Cancer. Einstein (Sao Paulo), 20, eAO6599.
https://doi.org/10.31744/einstein_journal/2022AO6599
|
[9]
|
Pozdnyakov, A., Kulanthaivelu, R., Bauman, G., et al. (2023) The Impact of PSMA PET on the Treatment and Outcomes of Men with Biochemical Recurrence of Prostate Cancer: A Systematic Review and Meta-Analysis. Prostate Cancer and Prostatic Diseases, 26, 240-248. https://doi.org/10.1038/s41391-022-00544-3
|
[10]
|
Rüschoff, J.H., Ferraro, D.A., Muehlematter, U.J., et al. (2021) What’s behind 68Ga-PSMA-11 Uptake in Primary Prostate Cancer PET? Investigation of Histopathological Parameters and Immunohistochemical PSMA Expression Patterns. European Journal of Nuclear Medicine and Molecular Imaging, 48, 4042-4053.
https://doi.org/10.1007/s00259-021-05501-1
|
[11]
|
Eiber, M., Weirich, G., Holzapfel, K., et al. (2016) Simultaneous 68Ga-PSMA HBED-CC PET/MRI Improves the Localization of Primary Prostate Cancer. European Urology, 70, 829-836. https://doi.org/10.1016/j.eururo.2015.12.053
|
[12]
|
Peng, L., Li, J., Meng, C., et al. (2020) Can 68Ga-Prostate Specific Membrane Antigen Positron Emission Tomography/Computerized Tomography Provide an Ac-curate Lymph Node Staging for Patients with Medium/High Risk Prostate Cancer? A Diagnostic Meta-Analysis. Radia-tion Oncology, 15, Article No. 227.
https://doi.org/10.1186/s13014-020-01675-4
|
[13]
|
Qiu, D.X., Li, J., Zhang, J.W., et al. (2022) Dual-Tracer PET/CT-Targeted, mpMRI-Targeted, Systematic Biopsy, and Combined Biopsy for the Diagnosis of Prostate Cancer: A Pilot Study. European Journal of Nuclear Medicine and Molecular Imaging, 49, 2821-2832. https://doi.org/10.1007/s00259-021-05636-1
|
[14]
|
Hoffmann, M.A., von Eyben, F.E., Fischer, N., et al. (2022) Comparison of [18F]PSMA-1007 with [68Ga]Ga-PSMA-11 PET/CT in Restaging of Prostate Cancer Patients with PSA Relapse. Cancers (Basel), 14, Article No. 1479.
https://doi.org/10.3390/cancers14061479
|
[15]
|
Seetharaman, A., Bhattacharya, I., Chen, L.C., et al. (2021) Auto-mated Detection of Aggressive and Indolent Prostate Cancer on Magnetic Resonance Imaging. Medical Physics, 48, 2960-2972. https://doi.org/10.1002/mp.14855
|
[16]
|
Xie, W., Reder, N.P., Koyuncu, C., et al. (2022) Prostate Can-cer Risk Stratification via Nondestructive 3D Pathology with Deep Learning-Assisted Gland Analysis. Cancer Research, 82, 334-345.
https://doi.org/10.1158/0008-5472.CAN-21-2843
|
[17]
|
Vergani, V., Razavi, R., Puyol-Antón, E., et al. (2021) Deep Learning for Classification and Selection of Cine CMR Images to Achieve Fully Automated Quality-Controlled CMR Analysis from Scanner to Report. Frontiers in Cardiovascular Medicine, 8, Article ID: 742640. https://doi.org/10.3389/fcvm.2021.742640
|
[18]
|
Bravi, C.A., Paciotti, M., Sarchi, L., et al. (2022) Robot-Assisted Radical Prostatectomy with the Novel Hugo Robotic System: Initial Experience and Optimal Surgical Set-Up at a Tertiary Referral Robotic Center. European Urology, 82, 233-237. https://doi.org/10.1016/j.eururo.2022.04.029
|
[19]
|
Spohn, S.K.B., Kramer, M., Kiefer, S., et al. (2020) Comparison of Manual and Semi-Automatic [18F]PSMA-1007 PET Based Contouring Techniques for Intraprostatic Tumor Delineation in Patients with Primary Prostate Cancer and Validation with Histopathology as Standard of Reference. Frontiers in Oncology, 10, Article ID: 600690.
https://doi.org/10.3389/fonc.2020.600690
|
[20]
|
Yi, Z., Hu, S., Lin, X., et al. (2022) Machine Learning-Based Pre-diction of Invisible Intraprostatic Prostate Cancer Lesions on 68Ga-PSMA-11 PET/CT in Patients with Primary Prostate Cancer. European Journal of Nuclear Medicine and Molecular Imaging, 49, 1523-1534. https://doi.org/10.1007/s00259-021-05631-6
|
[21]
|
Hinzpeter, R., Baumann, L., Guggenberger, R., et al. (2022) Ra-diomics for Detecting Prostate Cancer Bone Metastases Invisible in CT: A Proof-of-Concept Study. European Radiology, 32, 1823-1832.
https://doi.org/10.1007/s00330-021-08245-6
|
[22]
|
Zhao, Y., Gafita, A., Vollnberg, B., et al. (2020) Deep Neural Network for Automatic Characterization of Lesions on 68Ga-PSMA-11 PET/CT. European Journal of Nuclear Medicine and Molecular Imaging, 47, 603-613.
https://doi.org/10.1007/s00259-019-04606-y
|
[23]
|
Hartenstein, A., Lübbe, F., Baur, A.D.J., et al. (2020) Prostate Cancer Nodal Staging: Using Deep Learning to Predict 68Ga-PSMA-Positivity from CT Imaging Alone. Scientific Re-ports, 10, Article No. 3398.
https://doi.org/10.1038/s41598-020-60311-z
|
[24]
|
Holzschuh, J.C., Mix, M., Ruf, J., et al. (2023) Deep Learning based Automated Delineation of the Intraprostatic Gross Tumour Volume in PSMA-PET for Patients with Primary Prostate Cancer. Radiotherapy and Oncology, 2023, Article ID: 109774. https://doi.org/10.1016/j.radonc.2023.109774
|
[25]
|
Spohn, S.K.B., Schmidt-Hegemann, N.S., Ruf, J., et al. (2023) Development of PSMA-PET-Guided CT-Based Radiomic Signature to Predict Biochemical Recurrence after Salvage Ra-diotherapy. European Journal of Nuclear Medicine and Molecular Imaging, 50, 2537-2547. https://doi.org/10.1007/s00259-023-06195-3
|
[26]
|
Kendrick, J., Francis, R.J., Hassan, G.M., et al. (2022) Fully Automatic Prognostic Biomarker Extraction from Metastatic Prostate Lesion Segmentations in Whole-Body [68Ga]Ga-PSMA-11 PET/CT Images. European Journal of Nuclear Medicine and Molecular Imaging, 50, 67-79. https://doi.org/10.1007/s00259-022-05927-1
|
[27]
|
Cysouw, M.C.F., Jansen, B.H.E., van de Brug, T., et al. (2021) Machine Learning-Based Analysis of [18F]DCFPyL PET Radiomics for Risk Stratification in Primary Prostate Cancer. European Journal of Nuclear Medicine and Molecular Imaging, 48, 340-349. https://doi.org/10.1007/s00259-020-04971-z
|
[28]
|
Zang, S., Ai, S., Yang, R., et al. (2022) Development and Vali-dation of 68Ga-PSMA-11 PET/CT-Based Radiomics Model to Detect Primary Prostate Cancer. EJNMMI Research, 12, Article No. 63.
https://doi.org/10.1186/s13550-022-00936-5
|
[29]
|
Erle, A., Moazemi, S., Lütje, S., et al. (2021) Evaluating a Ma-chine Learning Tool for the Classification of Pathological Uptake in Whole-Body PSMA-PET-CT Scans. Tomography, 7, 301-312.
https://doi.org/10.3390/tomography7030027
|
[30]
|
Leung, K.H., Rowe, S.P., Leal, J.P., et al. (2022) Deep Learning and Radiomics Framework for PSMA-RADS Classification of Prostate Cancer on PSMA PET. EJNMMI Research, 12, Article No. 76.
https://doi.org/10.1186/s13550-022-00948-1
|
[31]
|
Gafita, A., Rauscher, I., Fendler, W.P., et al. (2022) Measuring Response in Metastatic Castration-Resistant Prostate Cancer Using PSMA PET/CT: Comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 Criteria. European Journal of Nuclear Medicine and Molecular Imaging, 49, 4271-4281.
https://doi.org/10.1007/s00259-022-05882-x
|
[32]
|
Ferdinandus, J., Violet, J., Sandhu, S., et al. (2020) Prognostic Biomarkers in Men with Metastatic Castration-Resistant Prostate Cancer Receiving [177Lu]-PSMA-617. European Jour-nal of Nuclear Medicine and Molecular Imaging, 47, 2322-2327. https://doi.org/10.1007/s00259-020-04723-z
|
[33]
|
Seifert, R., Herrmann, K., Kleesiek, J., et al. (2020) Semiauto-matically Quantified Tumor Volume Using (68)Ga-PSMA-11 PET as a Biomarker for Survival in Patients with Ad-vanced Prostate Cancer. Journal of Nuclear Medicine, 61, 1786-1792. https://doi.org/10.2967/jnumed.120.242057
|
[34]
|
Sartor, O., de Bono, J., Chi, K.N., et al. (2021) Luteti-um-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer. The New England Journal of Medicine, 385, 1091-1103. https://doi.org/10.1056/NEJMoa2107322
|
[35]
|
Capobianco, N., Sibille, L., Chantadisai, M., et al. (2022) Whole-Body Uptake Classification and Prostate Cancer Staging in 68Ga-PSMA-11 PET/CT Using Dual-Tracer Learning. European Journal of Nuclear Medicine and Molecular Imaging, 49, 517-526. https://doi.org/10.1007/s00259-021-05473-2
|
[36]
|
Ghezzo, S., Mapelli, P., Bezzi, C., et al. (2023) Role of [68Ga]Ga-PSMA-11 PET Radiomics to Predict Post-Surgical ISUP Grade in Primary Prostate Cancer. European Journal of Nuclear Medicine and Molecular Imaging, 50, 2548-2560.
https://doi.org/10.1007/s00259-023-06187-3
|
[37]
|
Yao, F., Bian, S., Zhu, D., et al. (2022) Machine Learning-Based Radiomics for Multiple Primary Prostate Cancer Biological Characteristics Prediction with 18F-PSMA-1007 PET: Com-parison among Different Volume Segmentation Thresholds. La Radiologia Medica, 127, 1170-1178. https://doi.org/10.1007/s11547-022-01541-1
|
[38]
|
Tran, V.T., Tu, S.J. and Tseng, J.R. (2022) 68Ga-PSMA-11 PET/CT Features Extracted from Different Radiomic Zones Predict Response to Androgen Deprivation Therapy in Pa-tients with Advanced Prostate Cancer. Cancers (Basel), 14, Article No. 4838. https://doi.org/10.3390/cancers14194838
|
[39]
|
Moazemi, S., Erle, A., Khurshid, Z., et al. (2021) Decision-Support for Treatment with 177Lu-PSMA: Machine Learning Predicts Response with High Accuracy Based on PSMA-PET/CT and Clinical Parameters. Annals of Translational Medicine, 9, Article No. 818. https://doi.org/10.21037/atm-20-6446
|
[40]
|
Moazemi, S., Erle, A., Lütje, S., et al. (2021) Estimating the Potential of Radiomics Features and Radiomics Signature from Pretherapeutic PSMA-PET-CT Scans and Clinical Data for Prediction of Overall Survival When Treated with 177Lu-PSMA. Diagnostics (Basel), 11, Article No. 186. https://doi.org/10.3390/diagnostics11020186
|
[41]
|
Kelk, E., Ruuge, P., Rohtla, K., et al. (2021) Radiomics Analysis for 177Lu-DOTAGA-(l-y)fk(Sub-KuE) Targeted Radioligand Therapy Dosimetry in Metastatic Prostate Cancer—A Model Based on Clinical Example. Life (Basel), 11, Article No. 170. https://doi.org/10.3390/life11020170
|
[42]
|
Castaldo, R., Cavaliere, C., Soricelli, A., et al. (2021) Radiomic and Ge-nomic Machine Learning Method Performance for Prostate Cancer Diagnosis: Systematic Literature Review. Journal of Medical Internet Research, 23, e22394.
https://doi.org/10.2196/22394
|
[43]
|
Panunzio, A., Tafuri, A., Princiotta, A., et al. (2021) Omics in Urology: An Overview on Concepts, Current Status and Future Perspectives. Urologia, 88, 270-279. https://doi.org/10.1177/03915603211022960
|